BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 100 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,635,483 | -24.7% | 1,963,583 | +32.6% | 0.00% | – |
| Q2 2023 | $7,480,994 | +422.5% | 1,481,385 | +95.5% | 0.00% | – |
| Q1 2023 | $1,431,836 | +5.0% | 757,585 | 0.0% | 0.00% | – |
| Q4 2022 | $1,363,653 | +6.5% | 757,585 | +0.1% | 0.00% | – |
| Q3 2022 | $1,280,000 | -21.8% | 757,098 | +13.9% | 0.00% | – |
| Q2 2022 | $1,636,000 | -12.7% | 664,957 | -1.7% | 0.00% | – |
| Q1 2022 | $1,875,000 | -65.3% | 676,687 | -33.3% | 0.00% | – |
| Q4 2021 | $5,409,000 | -41.9% | 1,014,791 | -7.7% | 0.00% | – |
| Q3 2021 | $9,304,000 | -51.1% | 1,099,823 | -29.5% | 0.00% | – |
| Q2 2021 | $19,021,000 | -58.2% | 1,560,459 | -16.8% | 0.00% | -100.0% |
| Q1 2021 | $45,512,000 | -23.1% | 1,875,985 | +1.6% | 0.00% | -50.0% |
| Q4 2020 | $59,164,000 | +20.5% | 1,845,962 | +13.7% | 0.00% | 0.0% |
| Q3 2020 | $49,097,000 | +39.4% | 1,624,152 | +94.4% | 0.00% | +100.0% |
| Q2 2020 | $35,225,000 | +123.0% | 835,506 | +32.0% | 0.00% | 0.0% |
| Q1 2020 | $15,794,000 | – | 632,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $86,074,000 | 4.50% |
| Boxer Capital, LLC | 2,014,858 | $50,271,000 | 3.43% |
| RA Capital Management | 2,589,904 | $64,618,000 | 2.04% |
| Artal Group S.A. | 1,696,517 | $42,328,000 | 1.79% |
| Logos Global Management LP | 123,465 | $2,772,000 | 1.05% |
| BVF INC/IL | 378,788 | $9,451,000 | 0.88% |
| Casdin Capital, LLC | 289,395 | $7,220,000 | 0.77% |
| Perceptive Advisors | 1,104,656 | $27,561,000 | 0.72% |
| Bellevue Group AG | 1,330,000 | $33,184,000 | 0.64% |
| Vivo Capital, LLC | 252,119 | $6,290,000 | 0.57% |